Board meeting on 7 October 2026 to consider increase in authorised share capital and preferential allotment fund raise
Dev Labtech Venture's Board will meet on Wednesday, 7 October 2026 at 3.00 p.m. at the company's Surat office.
- Board Meeting Date
- Wednesday, 7 October 2026 at 3.00 p.m.
- Meeting Venue
- Company's office in Surat
- Intimation Date
- 03/10/2026
- Trading Window Closed From
- 2nd October 2026 till 48 hours after price-sensitive information becomes generally available
- Agenda Items
- Increase in authorised share capital; consider raising funds via equity shares or eligible convertible securities through preferential…
What the company told the exchange
Dev Labtech Venture Limited has informed BSE that a meeting of its Board of Directors is scheduled to be held on Wednesday, 7 October 2026 at 3.00 p.m. at the Office of the Company situated at Plot No. 53 54, 1st Floor, Thakordwar Society, Mini Bazar, Varachha Road, Surat – 395006, Gujarat. The intimation is dated 03/10/2026, and the exchange headline lists the company under scrip code 543848 (BSE SME).
The two main items on the agenda
- To increase the authorised share capital of the Company.
- To consider and evaluate proposals for raising of funds by way of issue of equity shares or any other eligible convertible securities, through preferential allotment, subject to all such regulatory/statutory approvals as may be required, including the approval of shareholders of the Company.
The update also states that, other businesses will be transacted at the meeting.
What an increase in authorised share capital means
Authorised share capital is the ceiling on how much share capital a company can issue. It is a limit set in the company's constitutional documents, not the money already raised. Increasing the authorised share capital raises that ceiling. On its own, it does not mean shares have been issued or that money has come in. It is commonly the enabling step that creates room to issue fresh shares later.
What a preferential allotment means
A preferential allotment is an issue of shares or convertible securities to a specific set of investors, rather than to the public at large, usually at a price decided as per applicable rules. The update describes the item as a proposal the Board will consider and evaluate. The Board is also seeking the approval of shareholders, which is a separate step.
Why the two items are being placed together
The two agenda items sit together logically: an increase in authorised share capital can create headroom, and the fund-raising item is about issuing equity shares or other eligible convertible securities. Both are items for the Board to take up at the meeting.
Trading window
In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct, the Trading Window for dealing in the securities of the Company by all Insider(s)/Designated Person(s), including their immediate relatives, shall remain closed from 2nd October, 2026 till completion of 48 hours after the declaration of such Undisclosed Price Sensitive Information becomes generally available information.
What to watch for
- The outcome of the Board meeting scheduled for 7 October 2026.
- What the Board decides on the increase in authorised share capital and on the fund-raising proposal.
- The terms on which any preferential allotment is considered, and the approvals, including shareholders' approval, that follow.
How to read this kind of announcement
This is an intimation of a scheduled Board meeting with the main agenda items set out. It tells investors what will be taken up for consideration. The items described are proposals to be considered and evaluated, and any fund raise is subject to the regulatory and statutory approvals required, including shareholders' approval.
Also from Dev Labtech Venture
Board approves authorised capital rise to Rs. 31,00,00,000 and preferential issue of convertible warrants
7 Oct 2026
Board approves preferential issue of up to 1,37,00,000 convertible warrants at Rs. 13 each; authorised capital raised
7 Oct 2026
Board approves authorised capital rise to Rs. 31 crore and 1,37,00,000 convertible warrants on preferential basis
7 Oct 2026
More numbers
- Trading window closure period after declaration becomes public48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.